France Bed Holdings Co.,Ltd.

TSE:7840 Stok Raporu

Piyasa değeri: JP¥43.0b

France Bed HoldingsLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

France Bed HoldingsLtd has been growing earnings at an average annual rate of 6.9%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 3.4% per year. France Bed HoldingsLtd's return on equity is 8.3%, and it has net margins of 5.3%.

Anahtar bilgiler

6.9%

Kazanç büyüme oranı

9.1%

EPS büyüme oranı

Healthcare Sektör Büyümesi7.9%
Gelir büyüme oranı3.4%
Özkaynak getirisi8.3%
Net Marj5.3%
Sonraki Kazanç Güncellemesi08 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

France Bed HoldingsLtd (TSE:7840) Will Pay A Larger Dividend Than Last Year At ¥21.00

Mar 11
France Bed HoldingsLtd (TSE:7840) Will Pay A Larger Dividend Than Last Year At ¥21.00

France Bed HoldingsLtd (TSE:7840) Is Increasing Its Dividend To ¥21.00

Feb 26
France Bed HoldingsLtd (TSE:7840) Is Increasing Its Dividend To ¥21.00

Gelir ve Gider Dağılımı

France Bed HoldingsLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSE:7840 Gelir, gider ve kazançlar (JPY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2459,9973,17127,6140
31 Mar 2459,1513,13427,3020
31 Dec 2358,7052,63627,2880
30 Sep 2358,7002,71227,0930
30 Jun 2358,7822,77426,8610
31 Mar 2358,5782,70226,7130
31 Dec 2257,5542,54426,3930
30 Sep 2256,6642,49126,0210
30 Jun 2255,3922,34925,6450
31 Mar 2254,3982,55725,0810
31 Dec 2154,1132,62524,7630
30 Sep 2154,0102,74924,4990
30 Jun 2154,0512,77824,2900
31 Mar 2152,4302,29523,7920
31 Dec 2051,2051,95823,3020
30 Sep 2050,4991,70523,1180
30 Jun 2051,1941,54523,1180
31 Mar 2052,4301,52023,4250
31 Dec 1952,7552,91023,4930
30 Sep 1952,7972,57623,4130
30 Jun 1951,6462,42523,2640
31 Mar 1951,7642,59923,1280
31 Dec 1852,3331,57923,1330
30 Sep 1852,2071,74423,0280
30 Jun 1852,5291,90022,9220
31 Mar 1852,4101,80622,8280
31 Dec 1752,3062,20022,7900
30 Sep 1752,2412,09722,8590
30 Jun 1752,0511,88722,7980
31 Mar 1752,1261,93122,7560
31 Dec 1652,0081,20222,7030
30 Sep 1652,3771,33122,5640
30 Jun 1652,5491,38422,4400
31 Mar 1652,6441,40222,3100
31 Dec 1552,8601,36422,1950
30 Sep 1552,6091,18822,1920
30 Jun 1552,0771,03322,2410
31 Mar 1551,90790422,2910
31 Dec 1453,4221,00422,3960
30 Sep 1454,2031,14322,3040
30 Jun 1454,6081,31522,0730
31 Mar 1454,8911,39721,9390
31 Dec 1352,7281,28821,4790

Kaliteli Kazançlar: 7840 has high quality earnings.

Büyüyen Kar Marjı: 7840's current net profit margins (5.3%) are higher than last year (4.7%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 7840's earnings have grown by 6.9% per year over the past 5 years.

Büyüme Hızlandırma: 7840's earnings growth over the past year (14.3%) exceeds its 5-year average (6.9% per year).

Kazançlar vs. Sektör: 7840 earnings growth over the past year (14.3%) exceeded the Healthcare industry 9.6%.

Özkaynak Getirisi

Yüksek ROE: 7840's Return on Equity (8.3%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y